Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001288123-06-000003
Filing Date
2006-01-17
Accepted
2006-01-17 07:07:08
Documents
1
Period of Report
2006-01-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 4007
  Complete submission text file 0001288123-06-000003.txt   5756
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Issuer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1 SUNSET RIDGE LEXINGTON MA 02173
Business Address
AFEYAN NOUBAR (Reporting) CIK: 0001222012 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-29089 | Film No.: 06531277